<DOC>
	<DOCNO>NCT01581320</DOCNO>
	<brief_summary>A multicenter , randomize , double-blind , active-controlled , phase III clinical trial evaluate efficacy safety Dp-R206 Bonviva 16 week month improvement vitamin D postmenopausal woman osteoporosis .</brief_summary>
	<brief_title>Phase III Clinical Trial DP-R206 Bonvia In Postmenopausal Women With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Ibandronic acid</mesh_term>
	<criteria>Female 40 year old postmenopausal Subject history malignant cancer</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>